Biohaven’s bipolar disorder candidate has failed to improve mania symptoms in a phase 2/ ... across major depressive disorder (MDD), focal epilepsy and generalized epilepsy.
Biohaven in recent months has reported a clinical stumble in spinal muscular atrophy, alongside a Phase I readout for its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback